﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2024v5.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2026-01-08T13:25:03-05:00</ReturnTs>
    <TaxPeriodEndDt>2025-02-28</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>831836341</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>GARRISON &amp; COMPANY PLLC</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>PO BOX 3950</AddressLine1Txt>
        <CityNm>HAILEY</CityNm>
        <StateAbbreviationCd>ID</StateAbbreviationCd>
        <ZIPCd>83333</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990PF</ReturnTypeCd>
    <TaxPeriodBeginDt>2024-03-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>943297072</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>WEINSTEIN FAMILY FOUNDATION</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>WEIN</BusinessNameControlTxt>
      <PhoneNum>2087266205</PhoneNum>
      <USAddress>
        <AddressLine1Txt>2 EMBARCADERO CENTER SUITE 470</AddressLine1Txt>
        <CityNm>SAN FRANCISCO</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>94111</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>WILL WEINSTEIN</PersonNm>
      <PersonTitleTxt>DIRECTOR</PersonTitleTxt>
      <PhoneNum>2087266205</PhoneNum>
      <SignatureDt>2026-01-08</SignatureDt>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>false</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>RON GARRISON</PreparerPersonNm>
      <PTIN>P00082516</PTIN>
      <PhoneNum>2087266205</PhoneNum>
      <PreparationDt>2026-01-08</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2024</TaxYr>
    <BuildTS>2025-03-06 01:10:19Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="7">
    <IRS990PF documentId="RetDoc7">
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <FMVAssetsEOYAmt>177593</FMVAssetsEOYAmt>
      <MethodOfAccountingCashInd>X</MethodOfAccountingCashInd>
      <AnalysisOfRevenueAndExpenses>
        <ScheduleBNotRequiredInd>X</ScheduleBNotRequiredInd>
        <InterestOnSavRevAndExpnssAmt>18</InterestOnSavRevAndExpnssAmt>
        <InterestOnSavNetInvstIncmAmt>18</InterestOnSavNetInvstIncmAmt>
        <DividendsRevAndExpnssAmt>4092</DividendsRevAndExpnssAmt>
        <DividendsNetInvstIncmAmt>4092</DividendsNetInvstIncmAmt>
        <NetGainSaleAstRevAndExpnssAmt>-112795</NetGainSaleAstRevAndExpnssAmt>
        <GrossSalesPriceAmt>1419284</GrossSalesPriceAmt>
        <TotalRevAndExpnssAmt>-108685</TotalRevAndExpnssAmt>
        <TotalNetInvstIncmAmt>4110</TotalNetInvstIncmAmt>
        <AccountingFeesRevAndExpnssAmt referenceDocumentId="RetDoc1">4399</AccountingFeesRevAndExpnssAmt>
        <InterestRevAndExpnssAmt>15</InterestRevAndExpnssAmt>
        <InterestNetInvstIncmAmt>15</InterestNetInvstIncmAmt>
        <TaxesRevAndExpnssAmt referenceDocumentId="RetDoc6">191</TaxesRevAndExpnssAmt>
        <TaxesNetInvstIncmAmt>191</TaxesNetInvstIncmAmt>
        <OtherExpensesRevAndExpnssAmt referenceDocumentId="RetDoc5">102</OtherExpensesRevAndExpnssAmt>
        <OtherExpensesNetInvstIncmAmt>102</OtherExpensesNetInvstIncmAmt>
        <TotOprExpensesRevAndExpnssAmt>4707</TotOprExpensesRevAndExpnssAmt>
        <TotOprExpensesNetInvstIncmAmt>308</TotOprExpensesNetInvstIncmAmt>
        <TotOprExpensesDsbrsChrtblAmt>0</TotOprExpensesDsbrsChrtblAmt>
        <ContriPaidRevAndExpnssAmt>0</ContriPaidRevAndExpnssAmt>
        <ContriPaidDsbrsChrtblAmt>0</ContriPaidDsbrsChrtblAmt>
        <TotalExpensesRevAndExpnssAmt>4707</TotalExpensesRevAndExpnssAmt>
        <TotalExpensesNetInvstIncmAmt>308</TotalExpensesNetInvstIncmAmt>
        <TotalExpensesDsbrsChrtblAmt>0</TotalExpensesDsbrsChrtblAmt>
        <ExcessRevenueOverExpensesAmt>-113392</ExcessRevenueOverExpensesAmt>
        <NetInvestmentIncomeAmt>3802</NetInvestmentIncomeAmt>
      </AnalysisOfRevenueAndExpenses>
      <Form990PFBalanceSheetsGrp>
        <CashBOYAmt>8015</CashBOYAmt>
        <CashEOYAmt>3329</CashEOYAmt>
        <CashEOYFMVAmt>3329</CashEOYFMVAmt>
        <SavAndTempCashInvstBOYAmt>119153</SavAndTempCashInvstBOYAmt>
        <SavAndTempCashInvstEOYAmt>3526</SavAndTempCashInvstEOYAmt>
        <SavAndTempCashInvstEOYFMVAmt>3526</SavAndTempCashInvstEOYFMVAmt>
        <CorporateStockBOYAmt>163975</CorporateStockBOYAmt>
        <CorporateStockEOYAmt referenceDocumentId="RetDoc2">170739</CorporateStockEOYAmt>
        <CorporateStockEOYFMVAmt>170738</CorporateStockEOYFMVAmt>
        <OtherAssetsBOYAmt referenceDocumentId="RetDoc3">17927</OtherAssetsBOYAmt>
        <OtherAssetsEOYAmt referenceDocumentId="RetDoc3">17927</OtherAssetsEOYAmt>
        <TotalAssetsBOYAmt>309070</TotalAssetsBOYAmt>
        <TotalAssetsEOYAmt>195521</TotalAssetsEOYAmt>
        <TotalAssetsEOYFMVAmt>177593</TotalAssetsEOYFMVAmt>
        <TotalLiabilitiesEOYAmt>0</TotalLiabilitiesEOYAmt>
        <OrgDoesNotFollowFASB117Ind>X</OrgDoesNotFollowFASB117Ind>
        <RetainedEarningBOYAmt>309070</RetainedEarningBOYAmt>
        <RetainedEarningEOYAmt>195521</RetainedEarningEOYAmt>
        <TotNetAstOrFundBalancesBOYAmt>309070</TotNetAstOrFundBalancesBOYAmt>
        <TotNetAstOrFundBalancesEOYAmt>195521</TotNetAstOrFundBalancesEOYAmt>
        <TotalLiabilitiesNetAstBOYAmt>309070</TotalLiabilitiesNetAstBOYAmt>
        <TotalLiabilitiesNetAstEOYAmt>195521</TotalLiabilitiesNetAstEOYAmt>
      </Form990PFBalanceSheetsGrp>
      <ChgInNetAssetsFundBalancesGrp>
        <TotNetAstOrFundBalancesBOYAmt>309070</TotNetAstOrFundBalancesBOYAmt>
        <ExcessRevenueOverExpensesAmt>-113392</ExcessRevenueOverExpensesAmt>
        <SubtotalAmt>195678</SubtotalAmt>
        <OtherDecreasesAmt referenceDocumentId="RetDoc4">157</OtherDecreasesAmt>
        <TotNetAstOrFundBalancesEOYAmt>195521</TotNetAstOrFundBalancesEOYAmt>
      </ChgInNetAssetsFundBalancesGrp>
      <CapGainsLossTxInvstIncmDetail>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GINKGO BIOWORKS HOLDINGS INC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-02-28</AcquiredDt>
          <SoldDt>2024-03-01</SoldDt>
          <GrossSalesPriceAmt>19877</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>23752</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3875</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3875</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>STANDARD BIOTOOLS INC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-05-20</AcquiredDt>
          <SoldDt>2024-05-31</SoldDt>
          <GrossSalesPriceAmt>24434</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>26285</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1851</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1851</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ANGES ORD</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-05-27</AcquiredDt>
          <SoldDt>2024-07-16</SoldDt>
          <GrossSalesPriceAmt>6697</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>8043</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1346</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1346</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>CARDIFF ONCOLOGY IN</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-11-12</SoldDt>
          <GrossSalesPriceAmt>30899</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>28970</CostOrOtherBasisAmt>
          <GainOrLossAmt>1929</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1929</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>CARDIFF ONCOLOGY IN</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-12-17</AcquiredDt>
          <SoldDt>2024-12-20</SoldDt>
          <GrossSalesPriceAmt>10518</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>12719</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2201</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2201</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>IMMUNEERING</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-08-01</AcquiredDt>
          <SoldDt>2025-01-24</SoldDt>
          <GrossSalesPriceAmt>5375</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>4148</CostOrOtherBasisAmt>
          <GainOrLossAmt>1227</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1227</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>PACIFIC BIOSCIENCES OF CALIF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-03-04</SoldDt>
          <GrossSalesPriceAmt>23779</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>30654</CostOrOtherBasisAmt>
          <GainOrLossAmt>-6875</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-6875</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>STANDARD BIOTOOLS INC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-06-07</SoldDt>
          <GrossSalesPriceAmt>22878</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>26485</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3607</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3607</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>JAPANESE YEN</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-07-16</AcquiredDt>
          <SoldDt>2024-07-16</SoldDt>
          <GrossSalesPriceAmt>6739</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>6697</CostOrOtherBasisAmt>
          <GainOrLossAmt>42</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>42</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ENERFLEX LTD</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-11-12</AcquiredDt>
          <SoldDt>2024-11-14</SoldDt>
          <GrossSalesPriceAmt>38362</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>37667</CostOrOtherBasisAmt>
          <GainOrLossAmt>695</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>695</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>PHATHOM PHARMACEUTICALS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-11-19</AcquiredDt>
          <SoldDt>2024-12-20</SoldDt>
          <GrossSalesPriceAmt>3712</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>4671</CostOrOtherBasisAmt>
          <GainOrLossAmt>-959</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-959</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ARDELYX INC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-12-18</AcquiredDt>
          <SoldDt>2025-01-31</SoldDt>
          <GrossSalesPriceAmt>13237</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>11587</CostOrOtherBasisAmt>
          <GainOrLossAmt>1650</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1650</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ENERFLEX LTD</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-01-18</AcquiredDt>
          <SoldDt>2024-03-07</SoldDt>
          <GrossSalesPriceAmt>14340</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>11509</CostOrOtherBasisAmt>
          <GainOrLossAmt>2831</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2831</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>STANDARD BIOTOOLS INC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-05-23</AcquiredDt>
          <SoldDt>2024-06-10</SoldDt>
          <GrossSalesPriceAmt>11257</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>13327</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2070</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2070</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>PHATHOM PHARMACEUTICALS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-07-18</SoldDt>
          <GrossSalesPriceAmt>84201</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>79600</CostOrOtherBasisAmt>
          <GainOrLossAmt>4601</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>4601</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>CARDIFF ONCOLOGY IN</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-11-15</SoldDt>
          <GrossSalesPriceAmt>25890</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>35641</CostOrOtherBasisAmt>
          <GainOrLossAmt>-9751</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-9751</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>PHATHOM PHARMACEUTICALS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-12-23</SoldDt>
          <GrossSalesPriceAmt>17813</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>22372</CostOrOtherBasisAmt>
          <GainOrLossAmt>-4559</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-4559</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>IMMUNEERING</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-10-29</AcquiredDt>
          <SoldDt>2025-01-31</SoldDt>
          <GrossSalesPriceAmt>4715</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5261</CostOrOtherBasisAmt>
          <GainOrLossAmt>-546</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-546</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ENERFLEX LTD</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-01-18</AcquiredDt>
          <SoldDt>2024-03-08</SoldDt>
          <GrossSalesPriceAmt>16820</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>13500</CostOrOtherBasisAmt>
          <GainOrLossAmt>3320</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>3320</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>STANDARD BIOTOOLS INC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-06-11</SoldDt>
          <GrossSalesPriceAmt>23065</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>25800</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2735</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2735</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SENTINEL ONES</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-07-23</AcquiredDt>
          <SoldDt>2024-07-24</SoldDt>
          <GrossSalesPriceAmt>35425</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>36516</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1091</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1091</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>PHATHOM PHARMACEUTICALS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-08-16</AcquiredDt>
          <SoldDt>2024-11-20</SoldDt>
          <GrossSalesPriceAmt>8605</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>12050</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3445</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3445</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ARDELYX INC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-12-18</AcquiredDt>
          <SoldDt>2024-12-23</SoldDt>
          <GrossSalesPriceAmt>11600</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>11587</CostOrOtherBasisAmt>
          <GainOrLossAmt>13</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>13</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>PACB - EQUITY OPTIONS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2025-01-17</SoldDt>
          <CostOrOtherBasisAmt>15860</CostOrOtherBasisAmt>
          <GainOrLossAmt>-15860</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-15860</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ENERFLEX LTD</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-02-08</AcquiredDt>
          <SoldDt>2024-03-11</SoldDt>
          <GrossSalesPriceAmt>15345</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>12856</CostOrOtherBasisAmt>
          <GainOrLossAmt>2489</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2489</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>RVIAN AUTOMOTIVE</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-06-25</AcquiredDt>
          <SoldDt>2025-06-26</SoldDt>
          <GrossSalesPriceAmt>15420</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>15789</CostOrOtherBasisAmt>
          <GainOrLossAmt>-369</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-369</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>PHATHOM PHARMACEUTICALS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-07-29</SoldDt>
          <GrossSalesPriceAmt>57288</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>58144</CostOrOtherBasisAmt>
          <GainOrLossAmt>-856</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-856</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>PHATHOM PHARMACEUTICALS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-08-16</AcquiredDt>
          <SoldDt>2024-11-25</SoldDt>
          <GrossSalesPriceAmt>4452</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>6025</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1573</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1573</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>CARDIFF ONCOLOGY IN</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-12-24</SoldDt>
          <GrossSalesPriceAmt>19727</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>22641</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2914</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2914</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ENERFLEX LTD</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-02-22</AcquiredDt>
          <SoldDt>2024-03-13</SoldDt>
          <GrossSalesPriceAmt>15245</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>13223</CostOrOtherBasisAmt>
          <GainOrLossAmt>2022</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2022</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>INTELLIA THERAPEUTICS INC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2025-06-24</AcquiredDt>
          <SoldDt>2025-06-26</SoldDt>
          <GrossSalesPriceAmt>22225</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>25141</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2916</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2916</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>PHAT</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-07-29</AcquiredDt>
          <SoldDt>2024-08-15</SoldDt>
          <GrossSalesPriceAmt>6199</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5076</CostOrOtherBasisAmt>
          <GainOrLossAmt>1123</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1123</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>PHATHOM PHARMACEUTICALS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-08-16</AcquiredDt>
          <SoldDt>2024-12-02</SoldDt>
          <GrossSalesPriceAmt>4285</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>6025</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1740</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1740</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MANNKIND CORP</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-12-23</AcquiredDt>
          <SoldDt>2024-12-30</SoldDt>
          <GrossSalesPriceAmt>16175</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>17366</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1191</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1191</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>EYEPOINT PHARMACEUTICA</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-01-25</AcquiredDt>
          <SoldDt>2024-03-14</SoldDt>
          <GrossSalesPriceAmt>21396</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>24805</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3409</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3409</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>NOODLES &amp; CO</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-06-28</SoldDt>
          <GrossSalesPriceAmt>24143</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>20439</CostOrOtherBasisAmt>
          <GainOrLossAmt>3704</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>3704</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>NOODLES &amp; CO</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-04-25</AcquiredDt>
          <SoldDt>2024-09-10</SoldDt>
          <GrossSalesPriceAmt>6225</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>7181</CostOrOtherBasisAmt>
          <GainOrLossAmt>-956</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-956</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>PHATHOM PHARMACEUTICALS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-11-13</AcquiredDt>
          <SoldDt>2024-12-05</SoldDt>
          <GrossSalesPriceAmt>8474</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>9834</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1360</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1360</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HUDSON PACIFIC - REAL ESTATE INVESTM</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-11-26</AcquiredDt>
          <SoldDt>2024-12-05</SoldDt>
          <GrossSalesPriceAmt>26230</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>27458</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1228</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1228</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>WBA 03/15/24</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-02-26</AcquiredDt>
          <SoldDt>2024-03-15</SoldDt>
          <CostOrOtherBasisAmt>6281</CostOrOtherBasisAmt>
          <GainOrLossAmt>-6281</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-6281</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>JAPANESE YEN</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-07-17</AcquiredDt>
          <SoldDt>2024-07-17</SoldDt>
          <GrossSalesPriceAmt>6764</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>6739</CostOrOtherBasisAmt>
          <GainOrLossAmt>25</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>25</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>IMMUNEERING</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-09-13</SoldDt>
          <GrossSalesPriceAmt>11325</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>8169</CostOrOtherBasisAmt>
          <GainOrLossAmt>3156</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>3156</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ARDELYX INC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-11-20</AcquiredDt>
          <SoldDt>2024-12-05</SoldDt>
          <GrossSalesPriceAmt>13543</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>12232</CostOrOtherBasisAmt>
          <GainOrLossAmt>1311</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1311</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MANNKIND CORP</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-12-23</AcquiredDt>
          <SoldDt>2025-01-03</SoldDt>
          <GrossSalesPriceAmt>16120</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>17366</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1246</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1246</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>PACIFIC BIOSCIENCES OF CALIF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-04-15</SoldDt>
          <GrossSalesPriceAmt>37498</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>57870</CostOrOtherBasisAmt>
          <GainOrLossAmt>-20372</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-20372</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>IMMUNEERING</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-07-01</SoldDt>
          <GrossSalesPriceAmt>12080</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>15917</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3837</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3837</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>NOODLES &amp; CO</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-05-09</AcquiredDt>
          <SoldDt>2024-09-23</SoldDt>
          <GrossSalesPriceAmt>5342</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>10638</CostOrOtherBasisAmt>
          <GainOrLossAmt>-5296</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-5296</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ARDELYX INC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-12-09</SoldDt>
          <GrossSalesPriceAmt>26727</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>25377</CostOrOtherBasisAmt>
          <GainOrLossAmt>1350</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1350</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>RECURSION PHARMACEUTICALS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-12-23</AcquiredDt>
          <SoldDt>2025-01-07</SoldDt>
          <GrossSalesPriceAmt>18601</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>16375</CostOrOtherBasisAmt>
          <GainOrLossAmt>2226</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2226</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>PACIFIC BIOSCIENCES OF CALIF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-04-16</AcquiredDt>
          <SoldDt>2024-04-18</SoldDt>
          <GrossSalesPriceAmt>10800</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>12600</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1800</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1800</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>RIVIAN AUTOMOTIVE</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-07-01</AcquiredDt>
          <SoldDt>2024-07-02</SoldDt>
          <GrossSalesPriceAmt>36417</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>35650</CostOrOtherBasisAmt>
          <GainOrLossAmt>767</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>767</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>NOODLES &amp; CO</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-05-09</AcquiredDt>
          <SoldDt>2024-10-08</SoldDt>
          <GrossSalesPriceAmt>5313</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>10638</CostOrOtherBasisAmt>
          <GainOrLossAmt>-5325</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-5325</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>CARDIFF ONCOLOGY IN</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-12-09</AcquiredDt>
          <SoldDt>2024-12-10</SoldDt>
          <GrossSalesPriceAmt>35411</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>24647</CostOrOtherBasisAmt>
          <GainOrLossAmt>10764</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>10764</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ABCELLERA BIOLOGICS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2025-01-06</AcquiredDt>
          <SoldDt>2025-01-07</SoldDt>
          <GrossSalesPriceAmt>8050</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>8504</CostOrOtherBasisAmt>
          <GainOrLossAmt>-454</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-454</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OPTION HEALTHCARE INC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-05-01</AcquiredDt>
          <SoldDt>2024-05-02</SoldDt>
          <GrossSalesPriceAmt>74457</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>75660</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1203</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1203</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>RIVIAN AUTOMOTIVE</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-07-02</AcquiredDt>
          <SoldDt>2024-07-03</SoldDt>
          <GrossSalesPriceAmt>36710</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>36612</CostOrOtherBasisAmt>
          <GainOrLossAmt>98</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>98</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>TTEC - EQUITY OPTIONS U.S.</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-06-28</AcquiredDt>
          <SoldDt>2024-10-18</SoldDt>
          <CostOrOtherBasisAmt>4203</CostOrOtherBasisAmt>
          <GainOrLossAmt>-4203</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-4203</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>PHATHOM PHARMACEUTICALS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-11-18</AcquiredDt>
          <SoldDt>2024-12-12</SoldDt>
          <GrossSalesPriceAmt>3958</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>4507</CostOrOtherBasisAmt>
          <GainOrLossAmt>-549</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-549</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>CARDIFF ONCOLOGY INC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2025-01-06</AcquiredDt>
          <SoldDt>2025-01-07</SoldDt>
          <GrossSalesPriceAmt>10182</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>12109</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1927</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1927</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HERTIZ GLOBAL HLDGS INC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-05-06</AcquiredDt>
          <SoldDt>2024-05-08</SoldDt>
          <GrossSalesPriceAmt>24400</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>26043</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1643</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1643</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>IMMUNEERING</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-05-02</AcquiredDt>
          <SoldDt>2024-07-05</SoldDt>
          <GrossSalesPriceAmt>2600</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>3994</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1394</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1394</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>NOODLES &amp; CO</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-11-07</SoldDt>
          <GrossSalesPriceAmt>14890</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>29107</CostOrOtherBasisAmt>
          <GainOrLossAmt>-14217</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-14217</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>IMMUNEERING</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-05-03</AcquiredDt>
          <SoldDt>2024-12-13</SoldDt>
          <GrossSalesPriceAmt>8459</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>8350</CostOrOtherBasisAmt>
          <GainOrLossAmt>109</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>109</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>IMMUNEERING</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-05-03</AcquiredDt>
          <SoldDt>2025-01-08</SoldDt>
          <GrossSalesPriceAmt>5143</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>4175</CostOrOtherBasisAmt>
          <GainOrLossAmt>968</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>968</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>IMMUNEERING</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-04-30</AcquiredDt>
          <SoldDt>2024-05-10</SoldDt>
          <GrossSalesPriceAmt>13875</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>15395</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1520</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1520</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>APPLIED SCIENCE PRODUCTS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-07-01</AcquiredDt>
          <SoldDt>2024-07-08</SoldDt>
          <GrossSalesPriceAmt>16750</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>16247</CostOrOtherBasisAmt>
          <GainOrLossAmt>503</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>503</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>BIRCHTECH</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-10-21</AcquiredDt>
          <SoldDt>2024-11-11</SoldDt>
          <GrossSalesPriceAmt>9900</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>11650</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1750</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1750</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ARDELYX INC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-12-17</SoldDt>
          <GrossSalesPriceAmt>36760</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>43115</CostOrOtherBasisAmt>
          <GainOrLossAmt>-6355</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-6355</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>RECURSION PHARMACEUTICALS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-12-23</AcquiredDt>
          <SoldDt>2025-01-08</SoldDt>
          <GrossSalesPriceAmt>6980</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>6550</CostOrOtherBasisAmt>
          <GainOrLossAmt>430</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>430</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>PETCO HEALTH &amp; WELLNESS CO INC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-05-22</SoldDt>
          <GrossSalesPriceAmt>30617</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>25623</CostOrOtherBasisAmt>
          <GainOrLossAmt>4994</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>4994</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>APPLIED SCIENCE PRODUCTS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-07-09</SoldDt>
          <GrossSalesPriceAmt>14316</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>16508</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2192</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2192</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>PHATHOM PHARMACEUTICALS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-07-01</AcquiredDt>
          <SoldDt>2024-11-11</SoldDt>
          <GrossSalesPriceAmt>21276</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>17750</CostOrOtherBasisAmt>
          <GainOrLossAmt>3526</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>3526</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ARDELYX INC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-12-18</SoldDt>
          <GrossSalesPriceAmt>22624</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>28275</CostOrOtherBasisAmt>
          <GainOrLossAmt>-5651</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-5651</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>RECURSION PHARMACEUTICALS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-12-23</AcquiredDt>
          <SoldDt>2025-01-10</SoldDt>
          <GrossSalesPriceAmt>10225</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>9825</CostOrOtherBasisAmt>
          <GainOrLossAmt>400</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>400</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>NOODLES &amp; CO</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-04-23</AcquiredDt>
          <SoldDt>2024-05-23</SoldDt>
          <GrossSalesPriceAmt>8903</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>7004</CostOrOtherBasisAmt>
          <GainOrLossAmt>1899</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1899</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>APPLIED SCIENCE PRODUCTS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-07-10</SoldDt>
          <GrossSalesPriceAmt>29020</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>34633</CostOrOtherBasisAmt>
          <GainOrLossAmt>-5613</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-5613</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>PHATHOM PHARMACEUTICALS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <SoldDt>2024-11-12</SoldDt>
          <GrossSalesPriceAmt>15766</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>17858</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2092</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2092</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>CARDIFF ONCOLOGY IN</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-12-13</AcquiredDt>
          <SoldDt>2024-12-18</SoldDt>
          <GrossSalesPriceAmt>22208</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>19591</CostOrOtherBasisAmt>
          <GainOrLossAmt>2617</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2617</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ARDELYX INC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-12-18</AcquiredDt>
          <SoldDt>2025-01-21</SoldDt>
          <GrossSalesPriceAmt>12207</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>11588</CostOrOtherBasisAmt>
          <GainOrLossAmt>619</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>619</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapitalGainNetIncomeAmt>-112795</CapitalGainNetIncomeAmt>
        <NetShortTermCapitalGainLossAmt>-112426</NetShortTermCapitalGainLossAmt>
      </CapGainsLossTxInvstIncmDetail>
      <ExciseTaxBasedOnInvstIncmGrp>
        <InvestmentIncomeExciseTaxAmt>53</InvestmentIncomeExciseTaxAmt>
        <SubtotalAmt>53</SubtotalAmt>
        <TaxBasedOnInvestmentIncomeAmt>53</TaxBasedOnInvestmentIncomeAmt>
        <EstimatedPlusOvpmtIncmTxAmt>750</EstimatedPlusOvpmtIncmTxAmt>
        <TotalPaymentsAndCreditsAmt>750</TotalPaymentsAndCreditsAmt>
        <OverpaymentAmt>697</OverpaymentAmt>
        <AppliedToESTaxAmt>697</AppliedToESTaxAmt>
      </ExciseTaxBasedOnInvstIncmGrp>
      <StatementsRegardingActyGrp>
        <LegislativePoliticalActyInd>false</LegislativePoliticalActyInd>
        <MoreThan100SpentInd>false</MoreThan100SpentInd>
        <Form1120POLFiledInd>false</Form1120POLFiledInd>
        <ActivitiesNotPreviouslyRptInd>false</ActivitiesNotPreviouslyRptInd>
        <ChangesToArticlesOrBylawsInd>false</ChangesToArticlesOrBylawsInd>
        <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
        <OrganizationDissolvedEtcInd>false</OrganizationDissolvedEtcInd>
        <Section508eRqrSatisfiedInd>true</Section508eRqrSatisfiedInd>
        <AtLeast5000InAssetsInd>true</AtLeast5000InAssetsInd>
        <OrgReportOrRegisterStateCd>CA</OrgReportOrRegisterStateCd>
        <Form990PFFiledWithAttyGenInd>true</Form990PFFiledWithAttyGenInd>
        <PrivateOperatingFoundationInd>false</PrivateOperatingFoundationInd>
        <NewSubstantialContributorsInd>false</NewSubstantialContributorsInd>
        <OwnControlledEntityInd>false</OwnControlledEntityInd>
        <DonorAdvisedFundInd>false</DonorAdvisedFundInd>
        <ComplyWithPublicInspRqrInd>true</ComplyWithPublicInspRqrInd>
        <WebsiteAddressTxt>N/A</WebsiteAddressTxt>
        <IndividualWithBooksNm>GARRISON COMPANY PLLC</IndividualWithBooksNm>
        <PhoneNum>2087266205</PhoneNum>
        <LocationOfBooksUSAddress>
          <AddressLine1Txt>PO BOX 3950</AddressLine1Txt>
          <CityNm>HAILEY</CityNm>
          <StateAbbreviationCd>ID</StateAbbreviationCd>
          <ZIPCd>83333</ZIPCd>
        </LocationOfBooksUSAddress>
        <ForeignAccountsQuestionInd>false</ForeignAccountsQuestionInd>
      </StatementsRegardingActyGrp>
      <StatementsRegardingActy4720Grp>
        <SaleOrExchDisqualifiedPrsnInd>false</SaleOrExchDisqualifiedPrsnInd>
        <BrrwOrLendDisqualifiedPrsnInd>false</BrrwOrLendDisqualifiedPrsnInd>
        <FurnGoodsDisqualifiedPrsnInd>false</FurnGoodsDisqualifiedPrsnInd>
        <PayCompDisqualifiedPrsnInd>false</PayCompDisqualifiedPrsnInd>
        <TransferAstDisqualifiedPrsnInd>false</TransferAstDisqualifiedPrsnInd>
        <PaymentToGovernmentOfficialInd>false</PaymentToGovernmentOfficialInd>
        <UndistributedIncomePYInd>false</UndistributedIncomePYInd>
        <BusinessHoldingsInd>false</BusinessHoldingsInd>
        <JeopardyInvestmentsInd>false</JeopardyInvestmentsInd>
        <UncorrectedPYJeopardyInvstInd>false</UncorrectedPYJeopardyInvstInd>
        <InfluenceLegislationInd>false</InfluenceLegislationInd>
        <InfluenceElectionInd>false</InfluenceElectionInd>
        <GrantsToIndividualsInd>false</GrantsToIndividualsInd>
        <GrantsToOrganizationsInd>false</GrantsToOrganizationsInd>
        <NoncharitablePurposeInd>false</NoncharitablePurposeInd>
        <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
        <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
        <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
        <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      </StatementsRegardingActy4720Grp>
      <OfficerDirTrstKeyEmplInfoGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>WILL WEINSTEIN</PersonNm>
          <USAddress>
            <AddressLine1Txt>2 EMBARCADERO CENTER SUITE 470</AddressLine1Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94111</ZIPCd>
          </USAddress>
          <TitleTxt>DIRECTOR</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>000.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>MEGAN WEINSTEINHOWARD</PersonNm>
          <USAddress>
            <AddressLine1Txt>2 EMBARCADERO SUITE 470</AddressLine1Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94111</ZIPCd>
          </USAddress>
          <TitleTxt>DIRECTOR</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>000.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>ALEXA WEINSTEIN</PersonNm>
          <USAddress>
            <AddressLine1Txt>2 EMBARCADERO SUITE 470</AddressLine1Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94111</ZIPCd>
          </USAddress>
          <TitleTxt>DIRECTOR</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>000.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <CompOfHghstPdEmplOrNONETxt>NONE</CompOfHghstPdEmplOrNONETxt>
        <CompOfHghstPdCntrctOrNONETxt>NONE</CompOfHghstPdCntrctOrNONETxt>
      </OfficerDirTrstKeyEmplInfoGrp>
      <SumOfProgramRelatedInvstGrp>
        <Description1Txt>N/A</Description1Txt>
      </SumOfProgramRelatedInvstGrp>
      <MinimumInvestmentReturnGrp>
        <AverageMonthlyFMVOfSecAmt>139798</AverageMonthlyFMVOfSecAmt>
        <AverageMonthlyCashBalancesAmt>92500</AverageMonthlyCashBalancesAmt>
        <FMVAllOtherNoncharitableAstAmt>17927</FMVAllOtherNoncharitableAstAmt>
        <TotalFMVOfUnusedAssetsAmt>250225</TotalFMVOfUnusedAssetsAmt>
        <AdjustedTotalFMVOfUnusedAstAmt>250225</AdjustedTotalFMVOfUnusedAstAmt>
        <CashDeemedCharitableAmt>3753</CashDeemedCharitableAmt>
        <NetVlNoncharitableAssetsAmt>246472</NetVlNoncharitableAssetsAmt>
        <MinimumInvestmentReturnAmt>12324</MinimumInvestmentReturnAmt>
      </MinimumInvestmentReturnGrp>
      <DistributableAmountGrp>
        <MinimumInvestmentReturnAmt>12324</MinimumInvestmentReturnAmt>
        <TaxBasedOnInvestmentIncomeAmt>53</TaxBasedOnInvestmentIncomeAmt>
        <TotalTaxAmt>53</TotalTaxAmt>
        <DistributableBeforeAdjAmt>12271</DistributableBeforeAdjAmt>
        <DistributableBeforeDedAmt>12271</DistributableBeforeDedAmt>
        <DistributableAsAdjustedAmt>12271</DistributableAsAdjustedAmt>
      </DistributableAmountGrp>
      <PFQualifyingDistributionsGrp>
        <ExpensesAndContributionsAmt>0</ExpensesAndContributionsAmt>
        <QualifyingDistributionsAmt>0</QualifyingDistributionsAmt>
      </PFQualifyingDistributionsGrp>
      <UndistributedIncomeGrp>
        <DistributableAsAdjustedAmt>12271</DistributableAsAdjustedAmt>
        <ExcessDistributionCyovYr4Amt>2326</ExcessDistributionCyovYr4Amt>
        <ExcessDistributionCyovYr3Amt>7268</ExcessDistributionCyovYr3Amt>
        <ExcessDistributionCyovYr1Amt>2364</ExcessDistributionCyovYr1Amt>
        <TotalExcessDistributionCyovAmt>11958</TotalExcessDistributionCyovAmt>
        <ExcessDistriCyovAppCYCorpusAmt>11958</ExcessDistriCyovAppCYCorpusAmt>
        <ExcessDistributionCyovAppCYAmt>11958</ExcessDistributionCyovAppCYAmt>
        <UndistributedIncomeCYAmt>313</UndistributedIncomeCYAmt>
      </UndistributedIncomeGrp>
      <SupplementaryInformationGrp>
        <OnlyContriToPreselectedInd>X</OnlyContriToPreselectedInd>
      </SupplementaryInformationGrp>
      <AnalysisIncomeProducingActyGrp>
        <IntOnSavAndTempCashInvstGrp>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>18</ExclusionAmt>
        </IntOnSavAndTempCashInvstGrp>
        <DividendsAndInterestFromSecDtl>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>4092</ExclusionAmt>
        </DividendsAndInterestFromSecDtl>
        <GainSalesAstOthThanInvntryGrp>
          <ExclusionCd>26</ExclusionCd>
          <ExclusionAmt>-112795</ExclusionAmt>
        </GainSalesAstOthThanInvntryGrp>
        <SubtotalsIncmProducingActyGrp>
          <ExclusionAmt>-108685</ExclusionAmt>
        </SubtotalsIncmProducingActyGrp>
        <TotalIncomeProducingActyAmt>-108685</TotalIncomeProducingActyAmt>
      </AnalysisIncomeProducingActyGrp>
      <TrnsfrTransRlnNonchrtblEOGrp>
        <TrnsfrOfCashToNonchrtblEOInd>false</TrnsfrOfCashToNonchrtblEOInd>
        <TrnsfrOtherAssetNonchrtblEOInd>false</TrnsfrOtherAssetNonchrtblEOInd>
        <SalesOrExchangesOfAssetsInd>false</SalesOrExchangesOfAssetsInd>
        <PurchaseOfAssetsNonchrtblEOInd>false</PurchaseOfAssetsNonchrtblEOInd>
        <RentalOfFacilitiesOthAssetsInd>false</RentalOfFacilitiesOthAssetsInd>
        <ReimbursementArrangementsInd>false</ReimbursementArrangementsInd>
        <LoansOrLoanGuaranteesInd>false</LoansOrLoanGuaranteesInd>
        <PerformanceOfServicesEtcInd>false</PerformanceOfServicesEtcInd>
        <SharingOfFacilitiesEtcInd>false</SharingOfFacilitiesEtcInd>
        <RelationshipsNonchrtblEOInd>false</RelationshipsNonchrtblEOInd>
      </TrnsfrTransRlnNonchrtblEOGrp>
    </IRS990PF>
    <AccountingFeesSchedule documentId="RetDoc1">
      <AccountingFeesDetail>
        <CategoryTxt>INDIRECT ACCOUNTING FEES</CategoryTxt>
        <Amt>4399</Amt>
      </AccountingFeesDetail>
    </AccountingFeesSchedule>
    <InvestmentsCorpStockSchedule documentId="RetDoc2">
      <InvestmentsCorporateStockGrp>
        <StockNm>CONIFER SECURITIES</StockNm>
        <EOYBookValueAmt>170739</EOYBookValueAmt>
        <EOYFMVAmt>170738</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
    </InvestmentsCorpStockSchedule>
    <OtherAssetsSchedule documentId="RetDoc3">
      <OtherAssetsScheduleGrp>
        <Desc>RECEIVABLE</Desc>
        <BOYBookValueAmt>17927</BOYBookValueAmt>
        <EOYBookValueAmt>17927</EOYBookValueAmt>
      </OtherAssetsScheduleGrp>
    </OtherAssetsSchedule>
    <OtherDecreasesSchedule documentId="RetDoc4">
      <OtherDecreasesDetail>
        <Desc>NON-DEDUCT FROM PRIOR YEAR</Desc>
        <Amt>157</Amt>
      </OtherDecreasesDetail>
    </OtherDecreasesSchedule>
    <OtherExpensesSchedule documentId="RetDoc5">
      <OtherExpensesScheduleGrp>
        <Desc>EXPENSES</Desc>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>BANK CHARGES</Desc>
        <RevenueAndExpensesPerBooksAmt>102</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>102</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
    </OtherExpensesSchedule>
    <TaxesSchedule documentId="RetDoc6">
      <TaxesDetail>
        <CategoryTxt>INDIRECT TAXES/LICENSES</CategoryTxt>
        <Amt>191</Amt>
        <NetInvestmentIncomeAmt>191</NetInvestmentIncomeAmt>
      </TaxesDetail>
    </TaxesSchedule>
  </ReturnData>
</Return>